Structural basis of immunosuppression by the therapeutic antibody daclizumab - Wikidata - wikimedia - TriplyDB

Structural basis of immunosuppression by the therapeutic antibody daclizumab

Structural basis of immunosuppression by the therapeutic antibody daclizumab

http://www.wikidata.org/entity/Q27664283

about

Therapeutic efficacy of monthly subcutaneous injection of daclizumab in relapsing multiple sclerosis Human antibody 3E1 targets the HA stem region of H1N1 and H5N6 influenza A viruses.An update on the use of biologic therapies in the management of uveitis in Behçet's disease: a comprehensive review.Pharmacotherapy for uveitis: current management and emerging therapy.Pharmacotherapy of scleritis: current paradigms and future directions.Systemic treatment of vitreous inflammation.Systemic treatments for noninfectious vitreous inflammation.Impact of Immune-Modulatory Drugs on Regulatory T Cell.The emerging role of anti-CD25 directed therapies as both immune modulators and targeted agents in cancer.IgG light chain-independent secretion of heavy chain dimers: consequence for therapeutic antibody production and design.Molecular basis for the recognition of CCN1 by monoclonal antibody 093G9.

P2860

Q28066677-DF7107F8-B4AE-40BA-83F1-0A9EE5A259DA Q33815658-EC2EE1FE-E36E-4208-9F65-DF6F7C2954F4 Q33910781-47CCF4F4-2287-4AEB-99BD-23F23A6CAB47 Q34274075-63699905-0F0A-4D00-9BC9-68AF0904579D Q37466204-29D1F82C-0D93-4411-A31D-E52ED2B57288 Q38048774-7CE62B96-E655-4162-A27A-45A12EFA0291 Q38172090-036980DC-6CEE-40D3-84C0-9508D66BDC72 Q38918124-802FD54D-95F3-4DBF-B6FB-2CAE0CA52199 Q39338052-A221CD7F-93BB-45DA-BD99-FC7B7F655DC0 Q41528201-670FF20D-3133-4066-BBAE-16A4B3B717A3 Q48286077-33ECD461-2A84-4B87-ACDE-21048FB06D0D

P2860

Structural basis of immunosuppression by the therapeutic antibody daclizumab

http://www.wikidata.org/entity/Q27664283

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Structural basis of immunosuppression by the therapeutic antibody daclizumab

@ast

Structural basis of immunosuppression by the therapeutic antibody daclizumab

@en

Structural basis of immunosuppression by the therapeutic antibody daclizumab

@nl

type

label

Structural basis of immunosuppression by the therapeutic antibody daclizumab

@ast

Structural basis of immunosuppression by the therapeutic antibody daclizumab

@en

Structural basis of immunosuppression by the therapeutic antibody daclizumab

@nl

prefLabel

Structural basis of immunosuppression by the therapeutic antibody daclizumab

@ast

Structural basis of immunosuppression by the therapeutic antibody daclizumab

@en

Structural basis of immunosuppression by the therapeutic antibody daclizumab

@nl

P1433

Q27664283-72C13936-117D-48E9-87D8-39FD25E9C530

P1476

Q27664283-744C3254-7549-4F8A-9A1A-04804F9374E9

P2093

Q27664283-188B1C88-8ED7-44D8-A8A6-6A7EFBBFD130

Q27664283-454D612F-B249-4795-8681-8FEED9FDEA81

Q27664283-4D0F96AD-230A-4D5A-B248-0021EFFCF09A

Q27664283-A8A9181E-AE4F-4EFD-BD3E-0B6EB127F7A6

Q27664283-CA18F689-F4E9-4A85-B521-0B6C606FA564

Q27664283-E1F8FD44-87F7-42FD-8BFD-01EA51F0D06B

Q27664283-E54C7020-5D99-4592-B244-47F8F8053FDB

P2860

Q27664283-5038CD7B-F673-47BB-AC66-450B96F7AD6D

Q27664283-8D247C83-BEEA-44C2-BBB0-CE2F4FF9E74F

P2888

Q27664283-1C22832D-6350-42D0-9A78-421F758A1DA8

P304

Q27664283-ED230454-742B-4480-A885-AFC7798CD375

P31

Q27664283-5DFF471A-D307-4776-93BF-AE5D17A129DC

P3181

Q27664283-91FB6ABE-7EF1-4BC2-AD1E-2D1C844BA8BD

P356

Q27664283-C6EBD035-0972-400B-83E0-DF5D671DFDA3

P433

Q27664283-E293D42B-188D-4262-9B80-80AA2B6C4AC7

P478

Q27664283-B3A80639-B97E-4E9D-91FF-51551A95B598

P50

Q27664283-603746AB-3376-4141-AD8C-6B6803A78C33

P577

Q27664283-E058BBE8-5DE2-4CF4-A934-B98F8C193516

P5875

Q27664283-4F150D4D-EBEC-4B27-B9EE-6A9410DB761D

P6179

Q27664283-3BA759CF-1873-4865-8B4F-84311B208E7C

P698

Q27664283-6DD626D7-5879-4066-9CD2-CE2D55208E44

P921

Q27664283-45AF97D4-0983-4EF7-8E65-18508A1C83DD

Q27664283-B0A6F12D-264B-403D-B08E-C9CA8FCE6F91

P3181

P356

P1433

P1476

Structural basis of immunosuppression by the therapeutic antibody daclizumab

@en

P2093

Chen Zhong

http://www.w3.org/2001/XMLSchema#string

Dapeng Zhang

http://www.w3.org/2001/XMLSchema#string

Huaizu Guo

http://www.w3.org/2001/XMLSchema#string

Hui Yang

http://www.w3.org/2001/XMLSchema#string

Jianchuan Wang

http://www.w3.org/2001/XMLSchema#string

Jianping Ding

http://www.w3.org/2001/XMLSchema#string

Yajun Guo

http://www.w3.org/2001/XMLSchema#string

P2860

Generation of Peptide mimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2/neu.

The soluble interleukin-2 receptor: biology, function, and clinical application.

P2888

P304

1361-1371

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3569459

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/CR.2010.130

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46158615

http://www.w3.org/2001/XMLSchema#string

P6179

1000418932

http://www.w3.org/2001/XMLSchema#string

P698

20820193

http://www.w3.org/2001/XMLSchema#string

P921

immunosuppression